Cesmous study: Secondary effects and complications of foam sclerotherapy of the great and small saphenous veins. A prospective controlled trial involving 1025 patients;Étude cesmous: Effets secondaires et complications de la sclérothérapie à mousse de la grande et de la petite veine saphène. Étude prospective contrôlée incluant 1025 patients

Phlebologie - Annales Vasculaires

Volumn 62, Issue 4, 2009, Pages 29-39

  Gillet, J L ^a   Guedes, J M ^a   Guex, J J ^a   Hamel Desnos, C ^a   Schadeck, M ^a   Lausecker, M ^a   Allaert, F A ^b  

^a CHU du Bocage ^*  (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Complication; Foam sclerotherapy; Side effect; Venous insufficiency

Indexed keywords

EID: 84855683002     PISSN: 00318280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cavezzi A., Frullini A., Ricci S., Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8.
2. Belcaro G. M., et al. Foam-sderotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology 2003;54:307-15.
3. Hamel-Desnos C., Desnos P., Wollmann J. C., Ouvry P., Mako S., Allaert F. A. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol. Surg. 2003;29:1170-5.
4. Yamaki T., Nozaki M., Iwasaka S. Comparative study of duplexguided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol. Surg. 2004;30:718-22.
5. Barrett J. M., Allen B., Ockelford A., Goldman M. P. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol. Surg. 2004;30:6-12.
6. Schadeck M. Sclérose de la petite veine saphène: comment éviter les mauvais résultats ? Phlébologie 2004;57:165-9.
7. Bountouroglou D. G., Azzam M., Kakkos S. K., Pathmarajah M., Young P., Geroulakos G. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur. J. Vase. Endovasc. Surg. 2006 Jan; 31:93-100.
8. ® polidocanol microfoam compared with surgery or sclerotherapy in management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-90.
9. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur. J. Vase. Endovasc. Surg. 2006;32:577-83.
10. Bergan J., Pascarella L., Mekenas L. Venous disorders: treatment with sclerosant foam. J. Cardiovasc. Surg. 2006;47:9-18.
11. ® à 1% par cathéter court (Méthode MS): une efficacité durable confirmée par les résultats à 2 ans. Phlébologie 2006;59:339-42.
12. Ferrara F., Bernbach H. R. Les résultats de la sdérothérapie: suivi de 1000 crosses de la grande veine saphène à 10 ans. Phlébologie 2006;59:77-83.
13. Ceulen R. P., Bullens-Goessens Y. I., Pi-van de Venne S. J., Nelemans P. J., Veraart J. C., Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol. Surg. 2007 Mar; 33:276-81.
14. Hamel-Desnos C., Ouvry P., Benigni I. P., Boitelle G., Schadeck M., Desnos P., Allaert F. A. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study". Eur. J. Vase. Endovasc. Surg. 2007;34:723-9.
15. Jia X., Mowatt G., Burr J. M., Cassar K., Cook J., Fraser C. Systematic review of foam sclerotherapy for varicose veins. BJS 2007:94;925-36.
16. Rabe E., Otto J., Schliephake D., Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur. J. Vase. Endovasc. Surg. 2008 Feb; 35:238-45.
17. Ouvry P., Allaert F. A., Desnos P., Hamel-Desnos C. Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicentre Randomised Controlled Trial with a Two-year Follow-up. EJVES 2008;36:366-70.
18. Tessari L., Cavezzi A., Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol. Surg. 2001;27:58-60.
19. Frullini A., Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol. Surg. 2002;28:11-5.
20. Varcoe P. F. Ultrasound guided sclerotherapy: efficacy, adverse effects and dosing. An international survey. Aust. N. Z. J. Phlebol. 2003;7:17-24.
21. Benigni J. P., Ratinahirana H. Mousse de Polidocaol et migraine à aura. Phlébologie 2003;56:289-91.
22. Barrett J. M., Allen B., Ockelford A., Goldman M. P. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol. Surg. 2004;30:6-12.
23. Barrett J. M., Allen B., Ockelford A., Goldman M. P. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol. Surg. 2004;30:1386-90.
24. Guex J.J., Allaert F. A., Gillet J. L., Chleir F. Immediate and Midterm Complications of Sclerotherapy. Report of a Prospective Multi-Centric Registry of 12, 173 Sclerotherapy Sessions. Dermatol. Surg. 2005;31:123-8.
25. Alôs J., Carreno P., Lôpez J. A., Estadella B., Serra-Prat M., Marinel-Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur. J. Vase. Endovasc. Surg. 2006;31:101-7.
26. Forlee M. V., Grouden M., Moore D. J., Shanik G. Stroke after varicose vein foam injection sclerotherapy. J. Vase. Surg. 2006;43:162-4.
27. Smith P. C. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur. J. Vase. Endovasc. Surg. 2006;32:577-83.
28. Goldman P. M., Bergan J. J., Guex J. J. Complications and adverse sequelae of sclerotherapy. In: Sclerotherapy, treatment of varicose and telangiectatic leg veins. Fourth edition, Mosby Elsevier, 2007 ch 8; pp. 189-244.
29. Myers K. A., Jolley D., Clough A., Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: mediumterm results assessed by ultrasound surveillance. Eur. J. Vase. Endovasc. Surg. 2007;33:116-21.
30. Munavalli G. S., Weiss R. A. Complications of sclerotherapy. Semin. Cutan. Med. Surg. 2007;26:22-8.
31. Morrison N., Neuhardt D. L., Rogers C. R., McEown J., Morrison T., Johnson E., Salles-Cunha S. X. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J. Vase. Surg. 2008;47:830-6.
32. Bush R. G., Derrick M., Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-92.
33. Ceulen R. P., Sommer A., Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N. Engl. J. Med. 2008;358:1525-6.
34. Cappelli M., Molino Lova R., Ermini S., Ganglands I., Giannelli F., Zamboni P. Hemodynamics of the sapheno-femoral complex: an operational diagnosis of proximal femoral valve function. Int. Angiol. 2006;25:356-60.
35. Porter J. M., Moneta G. L., et al. International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J. Vase. Surg. 1995;27:635-45.
36. Eklöf B., Rutherford R. B., Bergan J. J., Carpentier P. H., Gloviczki P., Kistner R. L., Meissner M. H., Moneta G. L., Myers K., Padberg F. T., Perrin M., Ruckley C. V., Smith P. C., Wakefield T. W; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J. Vase. Surg. 2004;40:1248-52.
37. Breu F. X., Guggenbichler S., Wollmann J. C; Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37:90-5.
38. Natali J., Farman T. Implications medico-légales au cours du traitement sdérothérapique des varices. J. Mal. Vase. 1996;21:227-32.
39. Hanisch F., Müller T., Krivocuca M., Winterholler M. Stroke following variceal sclerotherapy. Eur. J. Med. Res. 2004;9:282-4.
40. Meier B., Lock J. E. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9.
41. Morrison N., Cavezzi A., Bergan J., Partsch H. Letter to the editor regarding "Stroke after varicose vein foam injection sclerotherapy". J. Vase. Surg 2007;44:224-5.
42. Cabrera J., Cabrera J. Jr., Garcia-Olmedo M. A., Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch. Dermatol. 2003;139:1409-16.
43. Hill D., Hamilton R., Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J. Vase. Surg. 2008;48:934-9.
44. Künzlberger B., Pieck C., Altmeyer P., Stücker M. Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol. Dermatol. Surg. 2006;32:1410-3.
45. Dowson A., Mullen M. J., Peatfield R., Muir K., Khan A. A., Wells C., Lipscombe S. L., Rees T., De Giovanni J. V., Morrison W. L., Hildick-Smith D., Elrington G., Hillis W. S., Malik I. S., Rickards A. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-404.
46. Ratinahirana H., Benigni J. P., Bousser M. G. Injection of polidocanol foam in varicose veins as a trigger for attacks of migraine with aura. Cephalalgia 2003;23:850-1.
47. Gillet J. L. Troubles visuels et neurologiques après injection de mousse sclérosante. Phlébologie 2009;62:26-30.
48. Gillet J. L., Donnet A., Lausecker M., Guedes J. M., Guex J. J., Lehmann P. Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010, in press.
49. Hamel-Desnos C., Guias B., Quéhé P., Mesgard A., Desnos P., Ferre B., Le Querrec A. Foam sclerotherapy of saphenous veins with or without medical support stocking (compression) - Biological effects of foam sclerotherapy-Randomized study [abstract]. 9th Annual Meeting of the European Venous Forum; 2008 June 26-28; Barcelona.
50. Gillet J. L., Perrin M., Cayman R. Thromboses veineuses superficielles des membres inférieurs. Étude prospective portant sur 100 patients. J. Mal. Vase. 2001;1:16-22.
51. MacDonald P. S., Kahn S. R., Miller N., Obrand D. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J. Vase. Surg. 2003;37:523-7.
52. Gillet J. L., Perrin M., Allaert F. A. Short and mid-term outcome of isolated symptomatic muscular calf vein thrombosis. J. Vase. Surg. 2007;46:513-9.
53. van Rij A. M., Chai J., Hill G. B., Christie R. A. Incidence of deep vein thrombosis after varicose vein surgery. Br. J. Surg. 2004;91:1582-5.
54. Weiss R. A., Weiss M. A. Controlled radiofrequency endovenous occlusion using a unique radiofrequency catheter under duplex guidance to eliminate saphenous varicose vein reflux: a 2-year follow-up. Dermatol. Surg. 2002;28:38-42.
55. Kistner R. L. Endovascular obliteration of the greater saphenous vein: the Closure procedure. Jpn. J. Phlebol. 2002;13:325-33.
56. Hingorani A. P., Ascher E., Markevich N., Schutzer R. W., Kallakuri S., Hou A., Nahata S., Yorkovich W., Jacob T. Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution. J. Vase. Surg. 2004;40:500-4.
57. Merchant R. F., Pichot O., Myers K. A. Four-year follow-up on endovascular radiofrequency obliteration of great saphenous reflux. Dermatol. Surg. 2005;31:129-34.
58. Min R. J., Zimmet S. E., Isaacs M. N., Forrestal M. D. Endovenous laser treatment of the incompetent greater saphenous vein. J. Vase. Interv. Radiol. 2001;12:1167-71.
59. Anastasie B., Celerier A., Cohen-Solal G., Anido R., Mordon S., et al. Laser endoveineux. Phlébologie 2003;56:369-82.
60. Proebstle T. M., Gül D., Kargl A., Knop J. Endovenous laser treatment of the lesser saphenous vein with a 940-nm diode laser: early results. Dermatol. Surg. 2003;29:357-61.
61. Mozes G., Kalra M., Carmo M., Swenson L., Gloviczki P. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J. Vase. Surg. 2005;41:130-5.